Message-ID:

6 May, 2024: The networking issue during the past two days has been identified and appears to be fixed. Will keep monitoring.

interests / alt.politics / Covid - Leading Monoclonals Not Very Effective With Omicron

Covid - Leading Monoclonals Not Very Effective With Omicron

<ab6dncKaTeEkUyL8nZ2dnUU7-WnNnZ2d@earthlink.com>

https://www.novabbs.com/interests/article-flat.php?id=13595&group=alt.politics#13595

copy link Newsgroups: talk.politics.misc alt.survival alt.politics alt.politics.usa soc.culture.usa

Path: i2pn2.org!rocksolid2!news.neodome.net!2.us.feeder.erje.net!feeder.erje.net!news.misty.com!border2.nntp.dca1.giganews.com!nntp.giganews.com!buffer2.nntp.dca1.giganews.com!buffer1.nntp.dca1.giganews.com!nntp.earthlink.com!news.earthlink.com.POSTED!not-for-mail
NNTP-Posting-Date: Sun, 19 Dec 2021 18:30:49 -0600
Newsgroups: talk.politics.misc,alt.survival,alt.politics,alt.politics.usa,soc.culture.usa
X-Mozilla-News-Host: news://news.west.earthlink.net:119
From: z24ba6....@nowhere (166p1)
Subject: Covid - Leading Monoclonals Not Very Effective With Omicron
Date: Sun, 19 Dec 2021 19:30:40 -0500
User-Agent: Mozilla/5.0 (X11; Linux x86_64; rv:68.0) Gecko/20100101
Thunderbird/68.12.0
MIME-Version: 1.0
Content-Type: text/plain; charset=utf-8; format=flowed
Content-Language: en-US
Content-Transfer-Encoding: 7bit
Message-ID: <ab6dncKaTeEkUyL8nZ2dnUU7-WnNnZ2d@earthlink.com>
Lines: 26
X-Usenet-Provider: http://www.giganews.com
NNTP-Posting-Host: 98.77.165.67
X-Trace: sv3-QRMn/z16vbwtuj81j1zNp3Z57LhbLdG+TcsHiT69XIGsDNd1E2uU6kaAsarxAOseDxIJOqZVu39w8Fe!oqly+NgJPh98OxAiFmcgvAEcrw/B43n1E0pUDwpm6E9hX5upLaZoZxD6lKzuCQPAG53ybCl3PggI!0aTwQ/+FT/x3YpVUe0Y=
X-Abuse-and-DMCA-Info: Please be sure to forward a copy of ALL headers
X-Abuse-and-DMCA-Info: Otherwise we will be unable to process your complaint properly
X-Postfilter: 1.3.40
X-Original-Bytes: 2164

by: 166p1 - Mon, 20 Dec 2021 00:30 UTC

https://medicalxpress.com/news/2021-12-omicron-sideline-drugs-covid-.html

As strained U.S. hospitals brace for a new surge of COVID-19
cases caused by the fast-spreading omicron variant, doctors
are warning of yet another challenge: the two standard drugs
they've used to fight infections are unlikely to work against
the new strain.

For more than a year antibody drugs from Regeneron and Eli Lilly
have been the go-to treatments for early COVID-19, thanks to their
ability to head off severe disease and keep patients out of the
hospital.

But both drugmakers recently warned that laboratory testing
suggests their therapies will be much less potent against omicron

.. . .

That's a problem with antibodies - they can be TOO specific.

The article says a Glaxo product is better, but not much
of it makes it into north America.

So, the Pfizer pill may be the best hope in case you
catch Omicron. Thing is, I don't know how plentiful
THOSE are yet either.

Subject	Author
Covid - Leading Monoclonals Not Very Effective With Omicron	166p1